IE43926L - 11,12-unsaturated-9ó-fluoro-steroids - Google Patents
11,12-unsaturated-9ó-fluoro-steroidsInfo
- Publication number
- IE43926L IE43926L IE761623A IE162376A IE43926L IE 43926 L IE43926 L IE 43926L IE 761623 A IE761623 A IE 761623A IE 162376 A IE162376 A IE 162376A IE 43926 L IE43926 L IE 43926L
- Authority
- IE
- Ireland
- Prior art keywords
- alpha
- unsaturated
- compounds
- novel
- fluorosteroids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
- C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
- C07J7/009—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by only one oxygen atom doubly bound
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/0026—Oxygen-containing hetero ring cyclic ketals
- C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Abstract
Novel 11,12-unsaturated 9 alpha -fluorosteroids, especially those of the androstane and pregnane series, with the following constitution in rings B and C <IMAGE> it being possible for all the substituents customary in the known pharmacological active steroids to be present in the remaining positions in the steroid framework and in the side chain, are prepared. Compounds of this type generally display pharmacological effects analogous to those of the corresponding known compounds; for example the derivatives derived from the known corticosteroids display a potent antiinflammatory effect with a relative reduction in the unwanted effect on the adrenals, thymus and body weight. The novel compounds are obtained by a novel type of chemical process, namely from corresponding 9 alpha -fluoro-11 beta -hydroxysteroids by dehydration using an N,N-disubstituted aminosulphur trifluoride. This process is generally applicable to the preparation of any desired 11,12-unsaturated 9 alpha -fluorosteroids.
[GB1520356A]
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH962075A CH611631A5 (en) | 1975-07-23 | 1975-07-23 | Process for the preparation of 11,12-unsaturated 9alpha-fluorosteroids |
Publications (2)
Publication Number | Publication Date |
---|---|
IE43926L true IE43926L (en) | 1977-01-23 |
IE43926B1 IE43926B1 (en) | 1981-07-01 |
Family
ID=4353884
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE1623/76A IE43926B1 (en) | 1975-07-23 | 1976-07-22 | 11,12-unsaturated-9-fluoro-steroids and a process for their manufacture |
Country Status (15)
Country | Link |
---|---|
JP (1) | JPS5214761A (en) |
AT (1) | AT353989B (en) |
AU (1) | AU505846B2 (en) |
BE (1) | BE844378A (en) |
CH (1) | CH611631A5 (en) |
DE (1) | DE2632550A1 (en) |
DK (1) | DK329976A (en) |
ES (1) | ES449989A1 (en) |
FR (1) | FR2318644A1 (en) |
GB (1) | GB1520356A (en) |
IE (1) | IE43926B1 (en) |
NL (1) | NL7608141A (en) |
NZ (1) | NZ181538A (en) |
SE (1) | SE7608369L (en) |
ZA (1) | ZA764405B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5423643A (en) * | 1977-07-22 | 1979-02-22 | Aikawa Tekko | Doctor blade stablizing apparatus |
DE3069074D1 (en) * | 1979-11-16 | 1984-10-04 | Sterosynt Ltd | 6-alpha-9-alpha-difluoro-16-beta-methyl-prednisolone-17,21 diesters and pharmaceutical compositions containing them |
FI911202A (en) * | 1990-12-28 | 1992-06-29 | Albany Int Corp | SCHABERBLAD. |
-
1975
- 1975-07-23 CH CH962075A patent/CH611631A5/en not_active IP Right Cessation
-
1976
- 1976-07-20 DE DE19762632550 patent/DE2632550A1/en active Pending
- 1976-07-21 FR FR7622212A patent/FR2318644A1/en active Granted
- 1976-07-21 ES ES449989A patent/ES449989A1/en not_active Expired
- 1976-07-22 IE IE1623/76A patent/IE43926B1/en unknown
- 1976-07-22 NZ NZ181538A patent/NZ181538A/en unknown
- 1976-07-22 AU AU16121/76A patent/AU505846B2/en not_active Expired
- 1976-07-22 BE BE169116A patent/BE844378A/en unknown
- 1976-07-22 GB GB30616/76A patent/GB1520356A/en not_active Expired
- 1976-07-22 DK DK329976A patent/DK329976A/en unknown
- 1976-07-22 AT AT539376A patent/AT353989B/en not_active IP Right Cessation
- 1976-07-22 ZA ZA764405A patent/ZA764405B/en unknown
- 1976-07-22 NL NL7608141A patent/NL7608141A/en not_active Application Discontinuation
- 1976-07-22 SE SE7608369A patent/SE7608369L/en unknown
- 1976-07-23 JP JP51087371A patent/JPS5214761A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
FR2318644A1 (en) | 1977-02-18 |
AU505846B2 (en) | 1979-12-06 |
NL7608141A (en) | 1977-01-25 |
ATA539376A (en) | 1979-05-15 |
BE844378A (en) | 1977-01-24 |
DE2632550A1 (en) | 1977-02-10 |
DK329976A (en) | 1977-01-24 |
FR2318644B1 (en) | 1978-12-15 |
SE7608369L (en) | 1977-01-24 |
ZA764405B (en) | 1977-08-31 |
AU1612176A (en) | 1978-01-26 |
AT353989B (en) | 1979-12-10 |
JPS5214761A (en) | 1977-02-03 |
NZ181538A (en) | 1978-09-20 |
ES449989A1 (en) | 1977-12-01 |
IE43926B1 (en) | 1981-07-01 |
CH611631A5 (en) | 1979-06-15 |
GB1520356A (en) | 1978-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Norymberski et al. | Partial reduction of steroid hormones and related substances | |
IE38617B1 (en) | Novel 11,11-alkylidene steroids | |
GB1329387A (en) | Selective microbiological preparation of androst-4-ene 3,17-dione | |
GB1502635A (en) | Process for splitting steroid ethers | |
IE44473L (en) | 6,9,21-trihalo pregnanes | |
IE43926L (en) | 11,12-unsaturated-9ó-fluoro-steroids | |
US3243434A (en) | 4, 5-and 6, 7-methylene pregnanes | |
GB1548259A (en) | Process for manufacture of steroid carboxylic acid lactones | |
JPS51149258A (en) | A process for preparing steroid derivatives | |
GB1472119A (en) | Electrocatalytic hydrogenation process | |
GB1180176A (en) | Novel Steroid 21-Esters, their Preparation, and Compositions containing them | |
AT274257B (en) | Process for the preparation of 17-oxygenated 3-oxo-Δ <4,9,11> -trienes of the 19-nor-androstane series | |
GB1228212A (en) | ||
GB1119081A (en) | New steroids | |
IE45670L (en) | 17ß-HYDROXY-3-OXO-17Ó-PREGNA-4-ENE-21-CARBOXYLIC ACID-Ô-¹LACTONE | |
GB930888A (en) | Improvements in or relating to the manufacture of steroids | |
GB1366329A (en) | Process for the manufacture of delta4-3-oxo-1alpha-methylsteroids | |
GB1291036A (en) | 7-methyl-7-hydroxy-steroids | |
IE39983B1 (en) | Process for the manufacture of 17 -oxalyl-steroids | |
GB1152180A (en) | delta<8(14)>-Steroids | |
JPS52144663A (en) | Preparation of pregnane steroid 17alpha-ester 21-halides | |
IE780606L (en) | A-nor-androstane and estrane steroids | |
GB1130115A (en) | 16-methyl-4-pregnen-3ªß-ol-20-ones and their preparation | |
DE3467351D1 (en) | Process for the preparation of 3-(delta-4-3-ketosteroid-17-alpha-yl)propionic acid lactones | |
GB1009918A (en) | Improvements in or relating to 6ª-lower alkanoylthio-4-en-3-one steroids and their preparation |